RangadhamNagarakantiMD

PubMed

• Atrial fibrillation ablation in heart failure with mid-range ejection fraction: Is it time to open the champagne?
  Rangadham Nagarakanti, Rakesh Gopinathannair> ;Indian Pacing and Electrophysiology Journal. 2023 Aug 31
• 1 citations
  Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Pro...
  Sanjeev Saksena, April Slee, Andrea Natale, Dhanunjaya R Lakkireddy, Dipen Shah, Luigi Di Biase, Thorsten Lewalter, Rangadham Nagarakanti, Pasquale Santangeli> ;Europace. 2023 May 19
• 6 citations
  Combined Use of Wells Scores and D-dimer Levels for the Diagnosis of Deep Vein Thrombosis and Pulmonary Embolism in COVID-19: A Retrospective Cohort Study.
  Kavin Raj, Sanya Chandna, Sotirios G. Doukas, Abi Watts, Keerthana Jyotheeswara Pillai, Anil Anandam, Dhruv Singh, Randy Nagarakanti, Kesavan Sankaramangalam> ;Cureus. 2021 Sep 3
• 1 citations
  Critical Role of the Posterior Left Atrium in the Perpetuation of Persistent Atrial Fibrillation and the Hybrid Ablation Approach for Persistent Atrial Fibrillation Ma...
  Rangadham Nagarakanti, Keung Ung, Hillary Strahan> ;The Journal of Innovations in Cardiac Rhythm Management. 2018 Oct 1
• Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulan...
  Ezekowitz MD, Nagarakanti R, Noack H, Brueckmann M, Litherland C, Jacobs M, Clemens A, Reilly PA, Connolly SJ, Yusuf S, Wallentin L> ;Circulation. 2016-08-23
• Three-dimensional mapping and intracardiac echocardiography in the treatment of sinoatrial nodal tachycardias.
  Ranghadham Nagarakanti, Sanjeev Saksena> ;Journal of Interventional Cardiac Electrophysiology. 2016 Jun 1
• 41 citations
  Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial).
  Rangadham Nagarakanti, Lars Wallentin, Herbert Noack, Martina Brueckmann, Paul A. Reilly, Andreas Clemens, Stuart J. Connolly, Salim Yusuf, Michael D. Ezekowitz> ;The American Journal of Cardiology. 2015 Oct 15
• 4 citations
  Left atrial reverse remodeling and prevention of progression of atrial fibrillation with atrial resynchronization device therapy utilizing dual-site right atrial pacin...
  Rangadham Nagarakanti, April Slee, Sanjeev Saksena> ;Journal of Interventional Cardiac Electrophysiology. 2014 Jul 31
• 39 citations
  Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left at...
  Daniel W. Kaiser, Megan Streur, Rangadham Nagarakanti, S. Patrick Whalen, Christopher R. Ellis> ;Journal of Interventional Cardiac Electrophysiology. 2013 Apr 28
• 45 citations
  Relation of Morbid Obesity and Female Gender to Risk of Procedural Complications in Patients Undergoing Atrial Fibrillation Ablation
  M. Benjamin Shoemaker, Raafia Muhammad, Maureen C. Farrell, Babar Parvez, Brenda W. White, Megan Streur, Tanya Stubblefield, Jason Rytlewski, Sunthosh Parvathaneni, Ra...> ;The American Journal of Cardiology. 2013 Feb 1
• 67 citations
  Common Atrial Fibrillation Risk Alleles at 4q25 Predict Recurrence after Catheter-based Atrial Fibrillation Ablation
  M. Benjamin Shoemaker, Raafia Muhammad, Babar Parvez, Brenda W. White, Megan Streur, Yanna Song, Tanya Stubblefield, Gayle Kucera, Marcia Blair, Jason Rytlewski, Sunth...> ;Heart Rhythm. 2013 Mar 1
• 12 citations
  Dabigatran in Clinical Practice
  Rangadham Nagarakanti, Christopher R. Ellis> ;Clinical Therapeutics. 2012 Oct 1
• 21 citations
  A randomized trial of budiodarone in paroxysmal atrial fibrillation
  Michael D. Ezekowitz, Rangadham Nagarakanti, Andrzej Lubiński, Olga Bandman, Daniel M. Canafax, David J. Ellis, Peter G. Milner, Margaret Ziola, Bernard Thibault, Stef...> ;Journal of Interventional Cardiac Electrophysiology. 2012 Jun 1
• 10 citations
  Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persisten...
  Rangadham Nagarakanti, Sanjeev Saksena, Douglas A. Hettrick, Jodi Koehler, Andrea Grammatico, Luigi Padeletti> ;Journal of Interventional Cardiac Electrophysiology. 2011 Jul 16
• 6 citations
  Atrial fibrillation: outpatient presentation and management.
  Michael D. Ezekowitz, Timothy H. Aikens, Rangadham Nagarakanti, Timothy Shapiro> ;Circulation. 2011 Jul 5
• 7 citations
  Dabigatran in atrial fibrillation: pharmacology and clinical trials
  Michael D. Ezekowitz, Rangadham Nagarakanti> ;Journal of Interventional Cardiac Electrophysiology. 2011 Jun 30
• Tall R waves in leads V1 to V3
  Rangadham Nagarakanti, D. Luke Glancy> ;Proceedings. 2010 Oct 1
• 12 citations
  Intracardiac echocardiography-guided cardiac resynchronization therapy: technique and clinical application.
  Sanjeev Saksena, Ann Marie Simon, Philip Mathew, Rangadham Nagarakanti> ;Pacing and Clinical Electrophysiology. 2009 Aug 1
• 39 citations
  Combination Antiplatelet Therapy for Secondary Stroke Prevention: Enhanced Efficacy or Double Trouble?
  M. Haris U. Usman, Lawrence A. Notaro, Rangadham Nagarakanti, Eric Brahin, Scott K. Dessain, Edward J. Gracely, Michael D. Ezekowitz> ;The American Journal of Cardiology. 2009 Apr 15
• Biatrial, 3-Dimensional Mapping of Human Atrial Fibrillation: Methodology and Clinical Observations.
  Nicholas D. Skadsberg, Rangadham Nagarakanti, Sanjeev Saksena> ;Journal of Atrial Fibrillation. 2009 Apr 1
• 2 citations
  The future of implantable defibrillator and cardiac resynchronization therapy trials
  Sanjeev Saksena, Rangadham Nagarakanti> ;Journal of Interventional Cardiac Electrophysiology. 2008 Aug 29
• 3 citations
  Chronic antithrombotic therapy in post-myocardial infarction patients.
  Rangadham Nagarakanti, Sandeep Sodhi, Robert Lee, Michael D. Ezekowitz> ;Cardiology Clinics. 2008 May 1
• 40 citations
  Diastolic dysfunction and atrial fibrillation.
  Rangadham Nagarakanti, Michael D. Ezekowitz> ;Journal of Interventional Cardiac Electrophysiology. 2008 Feb 9
• Letter Regarding Article by Connolly et al, “Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation”
  Michael D. Ezekowitz, Rangadham Nagarakanti> ;Circulation. 2008 Feb 5
• 347 citations
  Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).
  Michael D. Ezekowitz, Paul A. Reilly, Gerhard Nehmiz, Timothy A. Simmers, Rangadham Nagarakanti, Kambiz Parcham-Azad, K. Erik Pedersen, Dominick A. Lionetti, Joachim S...> ;The American Journal of Cardiology. 2007 Nov 1
• Join now to see all

Journal Articles

• Cardiac Amyloidosis Wild Type (ATTR-CAwt) and Associated Cardiac Arrhythmias: A Case Report and Literature Review  
  Rangadham Nagarakanti, Kesavan Sankaramangalam, Sindhu Nagarakanti, Danyaal Moin, Kenneth Dulnuan, Deepa B. Iyer, Indian Journal of Clinical Cardiology, 3/8/2021
• Critical role of posterior left atrium in perpetuation of persistent atrial fibrillation and the hybrid ablation approach for management  
  NAGARAKANTI, The journal of Innovations in Cardiac Rhythm Management, 9/2018